Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - 75 |
| Updated: | 4/21/2016 |
| Start Date: | June 2002 |
| End Date: | January 2011 |
Optimal management of patients with locally advanced breast cancer remains a complex
therapeutic problem. Newly diagnosed breast cancers in the United States with a higher
incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant
chemotherapy still remains controversial due to the difficulty of evaluating response to
therapy. The goal would be to prevent over and under treatment of patients with neoadjuvant
chemotherapy.
therapeutic problem. Newly diagnosed breast cancers in the United States with a higher
incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant
chemotherapy still remains controversial due to the difficulty of evaluating response to
therapy. The goal would be to prevent over and under treatment of patients with neoadjuvant
chemotherapy.
The Researcher developed a diagnostic device called Diffuse Optical Spectroscopy Imaging is
a non-invasive optical technique that utilizes intensity-modulated, near-infrared light to
quantitatively measure optical properties in thick tissues.
Diffuse Optical Spectroscopy Imaging can images tissue hemoglobin , oxygen saturation, blood
volume fraction, water content, fat content and cellular structure. The measurements provide
quantitative optical property values that reflect changes in tissue perfusion, oxygen
consumption, and cell/matrix development.
There is no therapeutic benefit to the subject, especially none that might influence the
indication for the diagnostic procedure as indicated. However, information obtained may lead
to a new form of non-invasive imaging for the early detection of breast cancer.
a non-invasive optical technique that utilizes intensity-modulated, near-infrared light to
quantitatively measure optical properties in thick tissues.
Diffuse Optical Spectroscopy Imaging can images tissue hemoglobin , oxygen saturation, blood
volume fraction, water content, fat content and cellular structure. The measurements provide
quantitative optical property values that reflect changes in tissue perfusion, oxygen
consumption, and cell/matrix development.
There is no therapeutic benefit to the subject, especially none that might influence the
indication for the diagnostic procedure as indicated. However, information obtained may lead
to a new form of non-invasive imaging for the early detection of breast cancer.
Inclusion Criteria:
- Female non-pregnant and age greater than or equal to 21 years old but less than 75
years old
- Diagnosed with breast cancer and will be receiving neoadjuvant chemotherapy
Exclusion Criteria:
- Female pregnant and age less than 21 years old and have no diagnosis of breast cancer
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials